Prevalence, predictors and outcomes of bleeding events in patients with COVID-19 infection on anticoagulation: Retrospective cohort study.

ABSTRACT:

Background

This study aims to examine risk factors and complications associated with bleeding events in patients with COVID-19 who are on anticoagulation.

Material and methods

We conducted retrospective review of all patients who were admitted with COVID-19 and developed bleeding events between March and June 2020. Data were analyzed in accordance with three major outcomes. Mortality within 30 days of bleeding episode, resolution of the bleeding event, and the type of bleeding event.

Results

Of 122 bleeds, there was 55 (28 %) gastrointestinal (GI) bleeds. Overall mortality was 59 % (n = 72). The prevalence of therapeutic invasive interventions was 11.5 % (n = 14) all were successful in resolving the bleeding event. We found that having a GI bleeds was associated with

SUBMITTER: Alkhamis A 

PROVIDER: S-EPMC8294630 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature